275 related articles for article (PubMed ID: 6719392)
21. A new genetic fibrinogen variant (fibrinogen Erfurt I). Structurally characterized by an abnormal B beta-chain and present both in plasma and platelets.
Meyer M; Schellenberg I; Vogel G; Bischoff I
Thromb Haemost; 1988 Apr; 59(2):138-42. PubMed ID: 3388290
[TBL] [Abstract][Full Text] [Related]
22. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
Malinconico SM; Katz JB; Budzynski AZ
J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of the S-carboxymethyl derivatives of crosslinked and noncrosslinked human fibrin.
McDonagh RP; McDonagh J; Blombäck B
Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3648-52. PubMed ID: 4509326
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen.
Francis CW; Marder VJ; Martin SE
J Biol Chem; 1980 Jun; 255(12):5599-604. PubMed ID: 6445903
[TBL] [Abstract][Full Text] [Related]
26. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
27. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
Schwartz ML; Pizzo SV; Hill RL; McKee PA
J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
[TBL] [Abstract][Full Text] [Related]
28. Reactivity of fibrinogen crosslinking sites in the absence of thrombin.
Seelich T; Furlan M; Beck EA
Thromb Haemost; 1976 Jun; 35(3):620-7. PubMed ID: 10637
[TBL] [Abstract][Full Text] [Related]
29. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
[TBL] [Abstract][Full Text] [Related]
30. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
[TBL] [Abstract][Full Text] [Related]
31. Quantitative determination of fibrin and fibrinogen in biological material.
Haeberli A; Straub PW
J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180
[TBL] [Abstract][Full Text] [Related]
32. [Electrophoretic patterns of differently prepared fibrinogen subunits in sodium dodecyl sulfate containing polyacrylamide gels].
Lober M; Krantz S
Acta Biol Med Ger; 1977; 36(10):1363-7. PubMed ID: 567415
[TBL] [Abstract][Full Text] [Related]
33. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin.
Haidaris PJ; Peerschke EI; Marder VJ; Francis CW
Blood; 1989 Nov; 74(7):2437-44. PubMed ID: 2478231
[TBL] [Abstract][Full Text] [Related]
34. Plasmic degradation of bovine fibrinogen and non-crosslinked fibrins in solution and in gel form.
Inoue N; Moroi M; Yamasaki M
Biochim Biophys Acta; 1975 Aug; 400(2):322-33. PubMed ID: 240417
[TBL] [Abstract][Full Text] [Related]
35. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
Peerschke EI; Galanakis DK
J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
[TBL] [Abstract][Full Text] [Related]
36. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
39. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
40. Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen.
Siebenlist KR; Mosesson MW
Biochemistry; 1996 May; 35(18):5817-21. PubMed ID: 8639542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
